Corporate Spotlight
BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutionise neurodevelopmental condition diagnosis like ASD and ADHD.
View the full Corporate Spotlight
PROF. WANG DISCUSSES BLINKLAB'S AI APP FOR AUTISM
Announcements
Filter Results
BB1 | Investor Presentation | 02/05/24 | ||
BB1 | BlinkLab Partnership with Turning Pointe Autism Foundation | 02/05/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Initial Director's Interest Notice x4 | 08/04/24 | ||
BB1 | Investor Presentation | 04/04/24 | ||
BB1 | Investor Webinar | 03/04/24 | ||
BB1 | BlinkLab to List on the ASX | 03/04/24 | ||
BB1 | Pre-Quotation Disclosure | 02/04/24 | ||
BB1 | Top 20 holders | 02/04/24 | ||
BB1 | Distribution schedule | 02/04/24 | ||
BB1 | Securities Trading Policy | 02/04/24 | ||
BB1 | Employee Securities Incentive Plan | 02/04/24 | ||
BB1 | Interim accounts to 31 December 2023 | 02/04/24 | ||
BB1 | Financial Accounts to 30 June 2023 | 02/04/24 | ||
BB1 | Financial Accounts to 30 June 2022 | 02/04/24 | ||
BB1 | Constitution | 02/04/24 | ||
BB1 | Replacement Prospectus | 02/04/24 | ||
BB1 | Appendix 1A and Information Form and Checklist | 02/04/24 | ||
BB1 | ASX Notice - Admission and Quotation | 02/04/24 | ||